Gabelli Funds LLC Acquires New Shares in Transphorm, Inc. (NASDAQ:TGAN)

Gabelli Funds LLC acquired a new stake in shares of Transphorm, Inc. (NASDAQ:TGANFree Report) during the first quarter, according to its most recent filing with the SEC. The fund acquired 284,200 shares of the company’s stock, valued at approximately $1,395,000. Gabelli Funds LLC owned 0.46% of Transphorm as of its most recent filing with the SEC.

Separately, Gamco Investors INC. ET AL bought a new stake in shares of Transphorm during the 1st quarter valued at $60,000. 66.45% of the stock is currently owned by institutional investors.

Transphorm Price Performance

NASDAQ TGAN remained flat at $5.10 during trading on Friday. The company has a market capitalization of $316.00 million, a P/E ratio of -7.39 and a beta of 0.57. The stock’s fifty day moving average is $4.97 and its two-hundred day moving average is $4.89. Transphorm, Inc. has a 1 year low of $1.94 and a 1 year high of $5.11.

Transphorm Company Profile

(Free Report)

Transphorm, Inc, a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe. The company's products include GaN field effect transistors in various packages.

Further Reading

Want to see what other hedge funds are holding TGAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transphorm, Inc. (NASDAQ:TGANFree Report).

Institutional Ownership by Quarter for Transphorm (NASDAQ:TGAN)

Receive News & Ratings for Transphorm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transphorm and related companies with MarketBeat.com's FREE daily email newsletter.